In the meta-analysis, SGLT2 inhibitors significantly reduced major adverse cardiovascular events (MACE), hospitalization for heart failure (HF) plus CV death, and progression of CKD by 11%, 23% and 33%, respectively, compared to placebo
These findings further highlight the transformative potential of retatrutide in improving both metabolic and cardiovascular health
The mechanism determines the side effects you will experience, how long you can safely take the medication, what monitoring your doctor needs to do, and ultimately how much weight you can expect to lose
Retrieved from DellAgli, M., Galli, G
cystine is translocated intracellularly by xCT and reduced to cysteine, which serves as a substrate for the antioxidant GSH (70)
moreover, homozygous individuals for GSTP1 105Ile allele, that encode the oxidative stress regulatory enzyme glutathione S-transferase pi 1, tend to suffer this type of NP more frequently than other people (Han and Smith, 2013)